RhumbLine Advisers’s Quipt Home Medical QIPT Stock Holding History

RhumbLine Advisers’s Portfolio QIPT Stock Details QIPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,827	Closed	-$90.5K	–	4236
2025 Q1	$90.5K	Sell	38,827 -3,052	-7%	-$8.37K	﹤0.01%	3422
2024 Q4	$128K	Buy	41,879 +904	+2%	+$2.43K	﹤0.01%	3399
2024 Q3	$120K	Sell	40,975 -8,301	-17%	-$25.6K	﹤0.01%	3450
2024 Q2	$159K	Buy	49,276 +8,541	+21%	+$30.6K	﹤0.01%	3353
2024 Q1	$178K	Buy	40,735 +626	+2%	+$2.83K	﹤0.01%	3235
2023 Q4	$204K	Sell	40,109 -718	-2%	-$3.44K	﹤0.01%	3178
2023 Q3	$208K	Buy	40,827 +1,893	+5%	+$10.1K	﹤0.01%	3141
2023 Q2	$208K	Buy	+38,934	New	+$230K	﹤0.01%	3222

Other funds holding QIPT

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RhumbLine Advisers's QIPT Position: Q2 2025 in Review

RhumbLine Advisers sold out of Quipt Home Medical (QIPT) in Q2 2025, closing a stake of 38,827 shares — an estimated $90.5K sold.

RhumbLine Advisers first reported a position in QIPT in Q2 2023 and held it in 8 quarters. The position peaked at $208K in Q2 2023. 75 funds tracked by Wall St. Rank hold QIPT as of Q2 2025.

RhumbLine Advisers reported no remaining Quipt Home Medical position as of Q2 2025 after selling out during the quarter.
RhumbLine Advisers sold 38,827 Quipt Home Medical shares in Q2 2025, an estimated $90.5K.
RhumbLine Advisers first reported a position in Quipt Home Medical in Q2 2023 and held it in 8 quarters.
RhumbLine Advisers's Quipt Home Medical position peaked at $208K in Q2 2023.
75 funds tracked by Wall St. Rank held Quipt Home Medical as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.